Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer
ConclusionsThe clinical performance of ApoA2-ATQ/AT as a blood biomarker is equivalent to or better than that of CA19-9.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Gastroenterology | Japan Health | Medical Devices | Pancreas | Pancreatic Cancer | Study